Bahl & Gaynor Inc. Has $5.32 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Bahl & Gaynor Inc. reduced its position in Teleflex Incorporated (NYSE:TFX) by 2.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 21,332 shares of the medical technology company’s stock after selling 448 shares during the period. Bahl & Gaynor Inc.’s holdings in Teleflex were worth $5,319,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Allworth Financial LP boosted its stake in shares of Teleflex by 332.3% during the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 103 shares during the period. Venturi Wealth Management LLC bought a new position in Teleflex during the third quarter worth $27,000. Covestor Ltd increased its holdings in shares of Teleflex by 305.6% in the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 110 shares during the last quarter. Lindbrook Capital LLC raised its position in shares of Teleflex by 75.3% in the fourth quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 58 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its stake in shares of Teleflex by 418.5% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after buying an additional 113 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Insider Activity at Teleflex

In other news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the sale, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.43% of the stock is currently owned by insiders.

Teleflex Stock Performance

Shares of NYSE TFX remained flat at $206.71 during mid-day trading on Friday. The company had a trading volume of 433,169 shares, compared to its average volume of 262,759. The firm has a market cap of $9.74 billion, a price-to-earnings ratio of 27.45, a price-to-earnings-growth ratio of 2.02 and a beta of 1.11. The company has a 50 day moving average price of $221.23 and a 200-day moving average price of $225.61. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, beating the consensus estimate of $3.26 by $0.12. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The firm had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. During the same period last year, the firm earned $3.52 EPS. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were paid a $0.34 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. Teleflex’s payout ratio is 18.06%.

Analyst Ratings Changes

Several research analysts have weighed in on TFX shares. Royal Bank of Canada lowered their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Truist Financial lowered their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research note on Friday, February 23rd. JMP Securities restated a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research note on Friday, February 23rd. Finally, StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $267.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.